Inhibrx Biosciences Inc
INBX80.210USD
-0.150-0.19%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
1.16BMarket Cap
LossP/E TTM
Inhibrx Biosciences Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
200.00K
-88.89%
EPS(YoY)
114.01
2326.24%
Analyst Rating
HOLD
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its total revenue reached 200.00K, with a year-on-year change of -88.89%.
What is the Earnings Per Share (EPS) of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 114.010, with a year-on-year change of 2326.24%.
What is the net income of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its net income was 1.69B, with a year-on-year change of 799.19%.
What is the net margin of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its net profit margin was 843786.00%, with a year-on-year change of 6392.71%.
What is the gross margin of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of -100.00%.
What is the Return on Equity (ROE) of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its Return on Equity (ROE) was 1905.92%, with a year-on-year change of 500.99%.
What is the Return on Assets (ROA) of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its Return on Assets (ROA) was 690.69%, with a year-on-year change of 956.74%.
What is the operating profit of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its operating profit was -331.45M, with a year-on-year change of -51.19%.
What are the current assets of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its current assets were 160.40M, with a year-on-year change of -45.69%.
What are the total assets of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its total assets of Inhibrx Biosciences Inc were 180.77M, with a year-on-year change of -41.29%.
What are the total liabilities of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its total liabilities of Inhibrx Biosciences Inc were 47.18M, with a year-on-year change of -82.15%.
What is the total equity of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its total equity of Inhibrx Biosciences Inc was 133.58M, with a year-on-year change of 207.07%.
What is the net operating income of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its net operating income of Inhibrx Biosciences Inc was 1.69B, with a year-on-year change of 803.96%.
What is the net investment of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its net investment of Inhibrx Biosciences Inc was -2.60M, with a year-on-year change of 43.46%.
What is the net financing of Inhibrx Biosciences Inc?
According to Inhibrx Biosciences Inc's FY2024 earnings report, its net financing of Inhibrx Biosciences Inc was 71.68M, with a year-on-year change of -64.51%.
